Industry News | tctmd.com

News Industry News

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

October 12, 2012

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Industry News

FDA Approves Medtronic Stent Graft for Aortic Transection Repair

November 12, 2012

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

Medis - a medical marketing company focused on branded pharmaceuticals and medical products in Central and Southeast Europe becomes a distributor for Orzone

October 08, 2012

News Industry News

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

September 20, 2012

News Industry News

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Industry News

Micro Interventional Devices, Inc. Initiates First-in-Man Clinical Study of Permaseal™

October 22, 2012

News Industry News

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

August 28, 2012

Subscribe to Industry News

Advertisement

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

FDA Approves Medtronic Stent Graft for Aortic Transection Repair

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

Medis - a medical marketing company focused on branded pharmaceuticals and medical products in Central and Southeast Europe becomes a distributor for Orzone

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Micro Interventional Devices, Inc. Initiates First-in-Man Clinical Study of Permaseal™

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content